Generex Biotechnology Corporation

OTCPK:GNBT Lagerbericht

Marktkapitalisierung: US$61.0k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Generex Biotechnology Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Joe Moscato

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführer5.4yrs
Eigentum des Geschäftsführers0.4%
Durchschnittliche Amtszeit des Managements5.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder5.4yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Joe Moscato im Vergleich zu den Einnahmen von Generex Biotechnology verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Apr 30 2021n/an/a

-US$37m

Jan 31 2021n/an/a

-US$52m

Oct 31 2020n/an/a

-US$35m

Jul 31 2020US$623kUS$623k

-US$33m

Apr 30 2020n/an/a

-US$26m

Jan 31 2020n/an/a

-US$31m

Oct 31 2019n/an/a

-US$36m

Jul 31 2019US$103kn/a

-US$9m

Apr 30 2019n/an/a

US$10m

Jan 31 2019n/an/a

US$24m

Oct 31 2018n/an/a

US$27m

Jul 31 2018US$100kn/a

US$36m

Apr 30 2018n/an/a

US$9m

Jan 31 2018n/an/a

-US$37m

Oct 31 2017n/an/a

-US$43m

Jul 31 2017US$50kn/a

-US$70m

Vergütung im Vergleich zum Markt: Insufficient data to establish whether Joe's total compensation is reasonable compared to companies of similar size in the US market.

Entschädigung vs. Einkommen: Joe's compensation has increased whilst the company is unprofitable.

Geschäftsführer

Joe Moscato (57 yo)

5.4yrs

Amtszeit

US$623,082

Vergütung

Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Mark Corrao
CFO & Treasurer5.4yrsUS$10.00k0%
$ 0
Terry Thompson
Chief Operating Officer4.4yrsUS$566.44k0%
$ 0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Anthony Crisci
Chief Legal Officer & Chief Administrative Officer2.8yrsUS$424.83k0%
$ 0
Anthony Dolisi
Chief Commercial Officer3.4yrskeine Daten1.08%
$ 658.9
Jason Terrell
Chief Scientific Officer & Chief Medical Officer5.4yrskeine Daten0%
$ 0
Michelle Starr
Chief Marketing Officer3.6yrskeine Datenkeine Daten
Richard Purcell
Executive Vice President of Research & Drug Development5.4yrsUS$68.33k0%
$ 0

5.4yrs

Durchschnittliche Betriebszugehörigkeit

56.5yo

Durchschnittliches Alter

Erfahrenes Management: GNBT's management team is seasoned and experienced (5.4 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Joseph Moscato
CEO, President & Chairman of the Board5.4yrsUS$623.08k0.36%
$ 219.0
Andrew Ro
Chief Investment Officer & Director5.4yrsUS$18.88k0%
$ 0
Brian McGee
Independent Director18.3yrsUS$47.20k0%
$ 0
Lawrence Salvo
Independent Director5.4yrsUS$18.88k0.26%
$ 160.2
Craig Eagle
Independent Director & Member of Scientific Advisory Board11.8yrsUS$47.20k0%
$ 0
James Anderson
Independent Director11yrsUS$118.33k0%
$ 0
Gary Noel
Member of Scientific Advisory Board1.7yrskeine Datenkeine Daten
Mark Prioletti
Independent Director3.2yrskeine Daten0%
$ 0
John Sanders
Member of Scientific Advisory Board1.7yrskeine Datenkeine Daten
Jonathan Davis
Member of Scientific Advisory Board1.7yrskeine Datenkeine Daten

5.4yrs

Durchschnittliche Betriebszugehörigkeit

59yo

Durchschnittliches Alter

Erfahrener Vorstand: GNBT's board of directors are considered experienced (5.4 years average tenure).